Jiangsu Hengrui Pharmaceuticals (01276) repurchased 335,000 A shares for RMB 14.5036 million on September 17.
Jiangsu Hengrui Pharmaceuticals (01276) announced that on September 17, 2026, it repurchased 335,000 A shares for RMB 14.5036 million.
Jiangsu Hengrui Pharmaceuticals (01276) announced that on September 17, 2026, it repurchased 335,000 A shares for RMB 14.5036 million.
Related Articles
Giansun Precision Technology Group (001400.SZ)'s major shareholder Lei Yijin plans to reduce holdings by no more than 3% of shares.
CCIAM FUTURE EN(00145): Huang Hongxin Appointed as Company Secretary
KKR, Blackstone, and others are bidding for GFL Environmental (GFL.US), a deal that could become one of the largest leveraged buyouts of the year.
Giansun Precision Technology Group (001400.SZ)'s major shareholder Lei Yijin plans to reduce holdings by no more than 3% of shares.
CCIAM FUTURE EN(00145): Huang Hongxin Appointed as Company Secretary
KKR, Blackstone, and others are bidding for GFL Environmental (GFL.US), a deal that could become one of the largest leveraged buyouts of the year.
RECOMMEND
